NEW YORK (GenomeWeb News) – Accelerate Diagnostics said after the close of the market on Monday that it has commenced a $45 million rights offering to fund the firm's product commercialization efforts.

The Tucson, Ariz.-based company is distributing at no charge to the holders of its common stock as of 5:00 PM EDT, March 14, 2014, .063921 non-transferable subscription rights for each share of stock owned.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.